Dropped head syndrome: report of three cases during treatment with a MEK inhibitor.
about
Cancer-treatment-induced neurotoxicity--focus on newer treatmentsEffect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial.Cardiogenic Shock and Respiratory Failure in a Patient With Metastatic Melanoma Receiving Trametinib TherapySmall molecule drugs with immunomodulatory effects in cancer.Dropped-head syndrome in a patient under treatment with the MEK inhibitor trametinib for NRAS-mutated metastatic melanoma.
P2860
Dropped head syndrome: report of three cases during treatment with a MEK inhibitor.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Dropped head syndrome: report of three cases during treatment with a MEK inhibitor.
@ast
Dropped head syndrome: report of three cases during treatment with a MEK inhibitor.
@en
type
label
Dropped head syndrome: report of three cases during treatment with a MEK inhibitor.
@ast
Dropped head syndrome: report of three cases during treatment with a MEK inhibitor.
@en
prefLabel
Dropped head syndrome: report of three cases during treatment with a MEK inhibitor.
@ast
Dropped head syndrome: report of three cases during treatment with a MEK inhibitor.
@en
P2093
P2860
P1433
P1476
Dropped head syndrome: report of three cases during treatment with a MEK inhibitor
@en
P2093
Gary K Schwartz
Richard D Carvajal
P2860
P304
P356
10.1212/WNL.0B013E318271F87E
P407
P577
2012-10-17T00:00:00Z